Investigation of the Effect of Dapagliflozin on Body Composition and Diet in Japanese Patients with Type 2 Diabetes Mellitus
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Apr 2017
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DIET
- 30 Sep 2016 Status changed from recruiting to active, no longer recruiting.
- 19 Oct 2015 Status changed from not yet recruiting to recruiting, as reported by University Hospital Medical Information Network - Japan.
- 07 Oct 2015 New trial record